Literature DB >> 18379567

The cancer stem cell hypothesis: in search of definitions, markers, and relevance.

Michail Shipitsin1, Kornelia Polyak.   

Abstract

Cancer is a disease of genes. Inherited or somatic alterations in genes are what make a normal cell ignore growth-controlling signals and form a tumor that eventually leads to the destruction of the organism. Based on accumulated knowledge on the genetic composition of cancer cells, the clonal evolution model of tumorigenesis was established, which explains multiple aspects of human disease and clinical observations. However, the recently popularized cancer stem cell hypothesis questions that all or most tumor cells can participate in tumor evolution and restricts this property to a subset of them defined as 'cancer stem cells' due to their stem cell-like characteristics. Enthusiasm surrounding this area of investigation and its presumed clinical implications led to a spurt of studies in various cancer types and model systems. Rigorous study design and critical data interpretation have to be employed to test the scientific and clinical relevance of the cancer stem cell hypothesis and its relationship to the clonal evolution model.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18379567      PMCID: PMC3702270          DOI: 10.1038/labinvest.2008.14

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


  27 in total

1.  Endothelial cells stimulate self-renewal and expand neurogenesis of neural stem cells.

Authors:  Qin Shen; Susan K Goderie; Li Jin; Nithin Karanth; Yu Sun; Natalia Abramova; Peter Vincent; Kevin Pumiglia; Sally Temple
Journal:  Science       Date:  2004-04-01       Impact factor: 47.728

Review 2.  Complexity of the human acute myeloid leukemia stem cell compartment: implications for therapy.

Authors:  John E Dick
Journal:  Biol Blood Marrow Transplant       Date:  2005-02       Impact factor: 5.742

3.  Prospective identification of tumorigenic prostate cancer stem cells.

Authors:  Anne T Collins; Paul A Berry; Catherine Hyde; Michael J Stower; Norman J Maitland
Journal:  Cancer Res       Date:  2005-12-01       Impact factor: 12.701

Review 4.  Stem cells, cancer, and cancer stem cells.

Authors:  T Reya; S J Morrison; M F Clarke; I L Weissman
Journal:  Nature       Date:  2001-11-01       Impact factor: 49.962

5.  Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell.

Authors:  D Bonnet; J E Dick
Journal:  Nat Med       Date:  1997-07       Impact factor: 53.440

Review 6.  AC133/CD133/Prominin-1.

Authors:  Sergey V Shmelkov; Ryan St Clair; David Lyden; Shahin Rafii
Journal:  Int J Biochem Cell Biol       Date:  2005-04       Impact factor: 5.085

7.  A cell initiating human acute myeloid leukaemia after transplantation into SCID mice.

Authors:  T Lapidot; C Sirard; J Vormoor; B Murdoch; T Hoang; J Caceres-Cortes; M Minden; B Paterson; M A Caligiuri; J E Dick
Journal:  Nature       Date:  1994-02-17       Impact factor: 49.962

8.  Induced pluripotent stem cell lines derived from human somatic cells.

Authors:  Junying Yu; Maxim A Vodyanik; Kim Smuga-Otto; Jessica Antosiewicz-Bourget; Jennifer L Frane; Shulan Tian; Jeff Nie; Gudrun A Jonsdottir; Victor Ruotti; Ron Stewart; Igor I Slukvin; James A Thomson
Journal:  Science       Date:  2007-11-20       Impact factor: 47.728

9.  Cancer stem cells: an old idea--a paradigm shift.

Authors:  Max S Wicha; Suling Liu; Gabriela Dontu
Journal:  Cancer Res       Date:  2006-02-15       Impact factor: 12.701

10.  Identification of a cancer stem cell in human brain tumors.

Authors:  Sheila K Singh; Ian D Clarke; Mizuhiko Terasaki; Victoria E Bonn; Cynthia Hawkins; Jeremy Squire; Peter B Dirks
Journal:  Cancer Res       Date:  2003-09-15       Impact factor: 12.701

View more
  75 in total

1.  Tracing the tumor lineage.

Authors:  Nicholas E Navin; James Hicks
Journal:  Mol Oncol       Date:  2010-05-05       Impact factor: 6.603

Review 2.  Molecular Classification and Future Therapeutic Challenges of Triple-negative Breast Cancer.

Authors:  Nikolaos Garmpis; Christos Damaskos; Anna Garmpi; Konstantinos Nikolettos; Dimitrios Dimitroulis; Evangelos Diamantis; Paraskevi Farmaki; Alexandros Patsouras; Errika Voutyritsa; Athanasios Syllaios; Constantinos G Zografos; Efstathios A Antoniou; Nikos Nikolettos; Alkiviadis Kostakis; Konstantinos Kontzoglou; Dimitrios Schizas; Afroditi Nonni
Journal:  In Vivo       Date:  2020 Jul-Aug       Impact factor: 2.155

3.  Novel retinoic acid derivative induces differentiation and growth arrest in neuroblastoma.

Authors:  Raoud Marayati; Adele P Williams; Laura V Bownes; Colin H Quinn; Jerry E Stewart; Elizabeth Mroczek-Musulman; Venkatram R Atigadda; Elizabeth A Beierle
Journal:  J Pediatr Surg       Date:  2020-02-28       Impact factor: 2.545

4.  CD133 expression is not selective for tumor-initiating or radioresistant cell populations in the CRC cell line HCT-116.

Authors:  Claudia Dittfeld; Antje Dietrich; Susann Peickert; Sandra Hering; Michael Baumann; Marian Grade; Thomas Ried; Leoni A Kunz-Schughart
Journal:  Radiother Oncol       Date:  2010-03       Impact factor: 6.280

5.  miR-7 suppresses brain metastasis of breast cancer stem-like cells by modulating KLF4.

Authors:  Hiroshi Okuda; Fei Xing; Puspa R Pandey; Sambad Sharma; Misako Watabe; Sudha K Pai; Yin-Yuan Mo; Megumi Iiizumi-Gairani; Shigeru Hirota; Yin Liu; Kerui Wu; Radhika Pochampally; Kounosuke Watabe
Journal:  Cancer Res       Date:  2013-02-05       Impact factor: 12.701

6.  Curcumin inhibits the side population (SP) phenotype of the rat C6 glioma cell line: towards targeting of cancer stem cells with phytochemicals.

Authors:  Dunne Fong; Arthur Yeh; Rotem Naftalovich; Theresa Hyejeong Choi; Marion M Chan
Journal:  Cancer Lett       Date:  2010-01-20       Impact factor: 8.679

7.  CD133, OCT4, and NANOG in ulcerative colitis-associated colorectal cancer.

Authors:  Hiromi Yasuda; Koji Tanaka; Yoshiki Okita; Toshimitsu Araki; Susumu Saigusa; Yuji Toiyama; Takeshi Yokoe; Shigeyuki Yoshiyama; Aya Kawamoto; Yasuhiro Inoue; Chikao Miki; Masato Kusunoki
Journal:  Oncol Lett       Date:  2011-09-06       Impact factor: 2.967

Review 8.  Stem cell origins and animal models of hepatocellular carcinoma.

Authors:  Rajagopal N Aravalli; Clifford J Steer; M Behnan Sahin; Erik N K Cressman
Journal:  Dig Dis Sci       Date:  2009-06-10       Impact factor: 3.199

9.  Rapid selection and proliferation of CD133+ cells from cancer cell lines: chemotherapeutic implications.

Authors:  Sarah E Kelly; Altomare Di Benedetto; Adelaide Greco; Candace M Howard; Vincent E Sollars; Donald A Primerano; Jagan V Valluri; Pier Paolo Claudio
Journal:  PLoS One       Date:  2010-04-08       Impact factor: 3.240

10.  Angiogenesis and vascular network of teratocarcinoma from embryonic stem cell transplant into seminiferous tubules.

Authors:  U Silván; J Arlucea; R Andrade; A Díez-Torre; M Silió; M A Konerding; J Aréchaga
Journal:  Br J Cancer       Date:  2009-06-09       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.